{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:48:23Z","timestamp":1784717303796,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.puhe.2023.11.026","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:44:26Z","timestamp":1702669466000},"page":"42-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5549-6216","authenticated-orcid":false,"given":"E.M.G.","family":"Olthof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4225-4354","authenticated-orcid":false,"given":"F.J.","family":"van Kemenade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.C.M.","family":"de Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2023.11.026_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000509546","article-title":"The impact of the COVID-19 pandemic and the associated Belgian governmental measures on cancer screening, surgical pathology and cytopathology","volume":"88","author":"De Pelsemaeker","year":"2021","journal-title":"Pathobiology"},{"key":"10.1016\/j.puhe.2023.11.026_bib2","series-title":"Preliminary results: rapid assessment of service delivery for noncommunicable diseases during the COVID-19 pandemic","first-page":"2021","year":"2020"},{"key":"10.1016\/j.puhe.2023.11.026_bib3","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1016\/S2468-2667(21)00078-5","article-title":"Cervical screening during the COVID-19 pandemic: optimising recovery strategies","volume":"6","author":"Castanon","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.puhe.2023.11.026_bib4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0969141318820362","article-title":"Key indicators of organized cancer screening programs: results from a Delphi study","volume":"26","author":"Csan\u00e1di","year":"2019","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.puhe.2023.11.026_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1460-0","article-title":"Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study","volume":"17","author":"Aitken","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.puhe.2023.11.026_bib6","series-title":"Monitor bevolkingsonderzoek baarmoederhalskanker 2019","year":"2020"},{"key":"10.1016\/j.puhe.2023.11.026_bib7","series-title":"Monitor bevolkingsonderzoek baarmoederhalskanker 2020","year":"2021"},{"key":"10.1016\/j.puhe.2023.11.026_bib8","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.puhe.2021.04.025","article-title":"Cervical screening coverage in England before and during COVID-19","volume":"198","author":"Armitage","year":"2021","journal-title":"Publ Health"},{"key":"10.1016\/j.puhe.2023.11.026_bib9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.puhe.2021.07.022","article-title":"The impact of COVID-19 on national screening programmes in England","volume":"198","author":"Armitage","year":"2021","journal-title":"Public health"},{"key":"10.1016\/j.puhe.2023.11.026_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/17455065211017070","article-title":"Cervical pap smears and pandemics: the effect of COVID-19 on screening uptake & opportunities to improve","volume":"17","author":"Masson","year":"2021","journal-title":"Women's Health"},{"key":"10.1016\/j.puhe.2023.11.026_bib11","article-title":"The impact of the COVID-19 pandemic on organised cervical cancer screening: the first results of the Slovenian cervical screening programme and registry","volume":"5","author":"Ivanu\u0161","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.puhe.2023.11.026_bib12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/1471-0528.16741","article-title":"The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study","volume":"128","author":"Meggetto","year":"2021","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.puhe.2023.11.026_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106559","article-title":"COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January\u2013June 2020, in the United States","volume":"151","author":"DeGroff","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.puhe.2023.11.026_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.puhe.2023.11.026_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106643","article-title":"The national FIT-based colorectal cancer screening program in The Netherlands during the COVID-19 pandemic","volume":"151","author":"Kortlever","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.puhe.2023.11.026_bib16","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/bjc.2017.111","article-title":"Self-sampling to improve cervical cancer screening coverage in Switzerland: a randomised controlled trial","volume":"116","author":"Viviano","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.puhe.2023.11.026_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1158\/1055-9965.EPI-14-0998","article-title":"Offering self-sampling to non-attendees of organized primary HPV screening: when do harms outweigh the benefits?","volume":"24","author":"Rozemeijer","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.puhe.2023.11.026_bib18","series-title":"Verbetermogelijkheden bevolkingsonderzoek baarmoederhalskanker","author":"Gezondheidsraad","year":"2021"},{"key":"10.1016\/j.puhe.2023.11.026_bib19","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.puhe.2023.11.026_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2019.04.025","article-title":"Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in The Netherlands","volume":"125","author":"Polman","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.puhe.2023.11.026_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2021.100235","article-title":"Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in The Netherlands: an observational study","volume":"11","author":"Inturrisi","year":"2021","journal-title":"The Lancet Regional Health-Europe"},{"key":"10.1016\/j.puhe.2023.11.026_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106596","article-title":"Impact of COVID-19 on cervical cancer screening: challenges and opportunities to improving resilience and reduce disparities","volume":"151","author":"Wentzensen","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.puhe.2023.11.026_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106623","article-title":"Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: a modelled analysis","volume":"151","author":"Smith","year":"2021","journal-title":"Prev Med"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350623004560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350623004560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:42:14Z","timestamp":1758501734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350623004560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":23,"alternative-id":["S0033350623004560"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2023.11.026","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2023.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}]}}